A Study of NWRD09 in Participants With Persistent HPV16 Infection in the Anal Region

NCT07710664 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Persistent HPV16 Infection

Interventions

DRUG: NWRD09

Sponsor

Newish Biotech (Wuxi) Co., Ltd.